Insider-Trading
Aktuelle Insider-Transaktionen (SEC Form 4) — Käufe und Verkäufe von Vorständen, Direktoren und Großaktionären.
| Ticker | Insider | Funktion | Datum | Transaktion | Kurs ($) | Stück | Wert ($) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| ELVR | Collard Sylvain | President Canada & Group COO | 02.11.2026 | Verkauf | 2,15 | 32.651 | 70.174 | Form 4 |
| ELVR | Collard Sylvain | President Canada & Group COO | 31.10.2026 | Optionsausübung | — | 52.075 | — | Form 4 |
| ELVN | Kunkel Lori Anne | Director | 30.10.2026 | Optionsausübung | 18,30 | 7.300 | 133.590 | Form 4 |
| ELVN | Kunkel Lori Anne | Director | 30.10.2026 | Optionsausübung | 1,12 | 3.741 | 4.190 | Form 4 |
| ELVR | Cortes Vargas Christian Mauricio | Chief Financial Officer | 28.10.2026 | Kauf | 2,67 | 8.000 | 21.360 | Form 4 |
| ELV | Kaye Mark | EVP & CFO | 22.10.2026 | Verkauf | 447,19 | 273 | 122.083 | Form 4 |
| ELV | Kaye Mark | EVP & CFO | 22.10.2026 | Verkauf | 446,05 | 827 | 368.883 | Form 4 |
| ELV | Kaye Mark | EVP & CFO | 22.10.2026 | Verkauf | 444,85 | 160 | 71.176 | Form 4 |
| ELV | Kaye Mark | EVP & CFO | 22.10.2026 | Verkauf | 443,81 | 440 | 195.276 | Form 4 |
| ELV | Kaye Mark | EVP & CFO | 22.10.2026 | Verkauf | 442,61 | 480 | 212.453 | Form 4 |
| ELV | Kaye Mark | EVP & CFO | 22.10.2026 | Verkauf | 441,34 | 2.343 | 1.034.060 | Form 4 |
| ELV | Kaye Mark | EVP & CFO | 22.10.2026 | Verkauf | 440,44 | 1.720 | 757.557 | Form 4 |
| ELV | Kaye Mark | EVP & CFO | 22.10.2026 | Verkauf | 439,25 | 1.160 | 509.530 | Form 4 |
| ELV | Kaye Mark | EVP & CFO | 22.10.2026 | Verkauf | 438,22 | 240 | 105.173 | Form 4 |
| ELV | Kaye Mark | EVP & CFO | 22.10.2026 | Verkauf | 437,07 | 560 | 244.759 | Form 4 |
| ELV | Kaye Mark | EVP & CFO | 22.10.2026 | Verkauf | 436,20 | 1.660 | 724.092 | Form 4 |
| ELV | Kaye Mark | EVP & CFO | 22.10.2026 | Verkauf | 435,25 | 321 | 139.715 | Form 4 |
| ELV | Kaye Mark | EVP & CFO | 22.10.2026 | Verkauf | 434,00 | 400 | 173.600 | Form 4 |
| ELVN | Hohl Benjamin | CHIEF FINANCIAL OFFICER | 19.10.2026 | Verkauf | 38,48 | 6.018 | 231.546 | Form 4 |
| ELVN | Hohl Benjamin | CHIEF FINANCIAL OFFICER | 19.10.2026 | Optionsausübung | 14,85 | 6.018 | 89.367 | Form 4 |
| ELVN | Collins Helen Louise | CHIEF MEDICAL OFFICER | 19.10.2026 | Verkauf | 38,47 | 5.000 | 192.342 | Form 4 |
| ELVN | Collins Helen Louise | CHIEF MEDICAL OFFICER | 19.10.2026 | Optionsausübung | 2,48 | 5.000 | 12.400 | Form 4 |
| ELV | Kaye Mark | EVP & CFO | 02.10.2026 | Zuteilung | — | 2.627 | — | Form 4 |
| ELV | Kaye Mark | EVP & CFO | 02.10.2026 | Steuer-Abgabe | 386,43 | 4.161 | 1.607.935 | Form 4 |
| ELVN | Garland J. Scott | Director | 01.10.2026 | Verkauf | 46,67 | 13.000 | 606.719 | Form 4 |
| ELVN | Garland J. Scott | Director | 01.10.2026 | Optionsausübung | 15,47 | 13.000 | 201.110 | Form 4 |
| ELVN | Hohl Benjamin | CHIEF FINANCIAL OFFICER | 17.09.2026 | Verkauf | 51,49 | 289 | 14.881 | Form 4 |
| ELVN | Hohl Benjamin | CHIEF FINANCIAL OFFICER | 17.09.2026 | Verkauf | 50,72 | 2.194 | 111.270 | Form 4 |
| ELVN | Hohl Benjamin | CHIEF FINANCIAL OFFICER | 17.09.2026 | Verkauf | 50,03 | 3.535 | 176.851 | Form 4 |
| ELVN | Hohl Benjamin | CHIEF FINANCIAL OFFICER | 17.09.2026 | Optionsausübung | 14,85 | 3.982 | 59.133 | Form 4 |
| ELVN | Collins Helen Louise | CHIEF MEDICAL OFFICER | 17.09.2026 | Verkauf | 51,48 | 240 | 12.356 | Form 4 |
| ELVN | Collins Helen Louise | CHIEF MEDICAL OFFICER | 17.09.2026 | Verkauf | 50,71 | 1.844 | 93.507 | Form 4 |
| ELVN | Collins Helen Louise | CHIEF MEDICAL OFFICER | 17.09.2026 | Verkauf | 50,03 | 2.916 | 145.891 | Form 4 |
| ELVN | Collins Helen Louise | CHIEF MEDICAL OFFICER | 17.09.2026 | Optionsausübung | 2,48 | 5.000 | 12.400 | Form 4 |
| ELV | Wessling Erin M | EVP & Chief Legal Officer | 03.09.2026 | Steuer-Abgabe | 414,78 | 255 | 105.769 | Form 4 |
| ELV | Wessling Erin M | EVP & Chief Legal Officer | 02.09.2026 | Steuer-Abgabe | 405,84 | 94 | 38.149 | Form 4 |
| ELV | Craig Ryan R | EVP & Chief HR Officer | 02.09.2026 | Steuer-Abgabe | 405,84 | 144 | 58.441 | Form 4 |
| ELVN | Hohl Benjamin | CHIEF FINANCIAL OFFICER | 17.08.2026 | Verkauf | 59,35 | 1.388 | 82.383 | Form 4 |
| ELVN | Hohl Benjamin | CHIEF FINANCIAL OFFICER | 17.08.2026 | Verkauf | 58,35 | 4.630 | 270.168 | Form 4 |
| ELVN | Collins Helen Louise | CHIEF MEDICAL OFFICER | 17.08.2026 | Verkauf | 59,35 | 1.100 | 65.281 | Form 4 |
| ELVN | Collins Helen Louise | CHIEF MEDICAL OFFICER | 17.08.2026 | Verkauf | 58,37 | 3.900 | 227.650 | Form 4 |
| ELVN | Collins Helen Louise | CHIEF MEDICAL OFFICER | 17.08.2026 | Optionsausübung | 2,48 | 5.000 | 12.400 | Form 4 |
| ELVN | Derynck Mika K | Director | 04.08.2026 | Verkauf | 60,21 | 158.795 | 9.561.587 | Form 4 |
| ELVN | Derynck Mika K | Director | 04.08.2026 | Optionsausübung | 22,47 | 20.491 | 460.433 | Form 4 |
| ELVN | Derynck Mika K | Director | 04.08.2026 | Optionsausübung | 14,85 | 23.364 | 346.955 | Form 4 |
| ELVN | Derynck Mika K | Director | 04.08.2026 | Optionsausübung | 25,28 | 27.567 | 696.894 | Form 4 |
| ELVN | Derynck Mika K | Director | 04.08.2026 | Optionsausübung | 2,48 | 87.373 | 216.685 | Form 4 |
| ELVN | Hohl Benjamin | CHIEF FINANCIAL OFFICER | 17.07.2026 | Verkauf | 53,87 | 123 | 6.626 | Form 4 |
| ELVN | Hohl Benjamin | CHIEF FINANCIAL OFFICER | 17.07.2026 | Verkauf | 53,38 | 2.638 | 140.823 | Form 4 |
| ELVN | Hohl Benjamin | CHIEF FINANCIAL OFFICER | 17.07.2026 | Verkauf | 52,32 | 2.564 | 134.143 | Form 4 |
| ELVN | Hohl Benjamin | CHIEF FINANCIAL OFFICER | 17.07.2026 | Verkauf | 51,48 | 369 | 18.997 | Form 4 |
| ELVN | Hohl Benjamin | CHIEF FINANCIAL OFFICER | 17.07.2026 | Verkauf | 49,97 | 324 | 16.191 | Form 4 |
| ELVN | Hohl Benjamin | CHIEF FINANCIAL OFFICER | 17.07.2026 | Optionsausübung | 2,48 | 1.072 | 2.659 | Form 4 |
| ELVN | Collins Helen Louise | CHIEF MEDICAL OFFICER | 17.07.2026 | Verkauf | 53,92 | 63 | 3.397 | Form 4 |
| ELVN | Collins Helen Louise | CHIEF MEDICAL OFFICER | 17.07.2026 | Verkauf | 53,42 | 2.184 | 116.669 | Form 4 |
| ELVN | Collins Helen Louise | CHIEF MEDICAL OFFICER | 17.07.2026 | Verkauf | 52,39 | 2.063 | 108.085 | Form 4 |
| ELVN | Collins Helen Louise | CHIEF MEDICAL OFFICER | 17.07.2026 | Verkauf | 51,55 | 459 | 23.660 | Form 4 |
| ELVN | Collins Helen Louise | CHIEF MEDICAL OFFICER | 17.07.2026 | Verkauf | 50,05 | 231 | 11.563 | Form 4 |
| ELVN | Collins Helen Louise | CHIEF MEDICAL OFFICER | 17.07.2026 | Optionsausübung | 2,48 | 5.000 | 12.400 | Form 4 |
| ELV | Boudreaux Gail | President and CEO | 17.07.2026 | Kauf | 368,25 | 2.045 | 753.071 | Form 4 |
Kompakter Markt-Überblick — keine Anlageberatung. Quelle: Fundamentaldaten & SEC-Berichte (Geschäfts- und Quartalsberichte, 10-K/10-Q).